Clinical Trial Update: An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH [Phase 1]

View source ↗

Summary

An open-label Phase 1 dose-escalation study evaluating the safety, tolerability, and preliminary efficacy of intravenous pump-delivered propranolol to prevent s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Stroke-associated Pneumonia

Drugs mentioned

• Propranolol (Inderal) (propranolol)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Intracerebral Hemorrhage, Stroke-Associated Pneumonia (SAP) | Phase 1 | Status: NOT_YET_RECRUITING